These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 3807085)

  • 41. Renal cell carcinoma: considerations for nephron-sparing surgery.
    Lerner SE; Tsai H; Flanigan RC; Trump DL; Fleischmann J
    Urology; 1995 Apr; 45(4):574-7. PubMed ID: 7716836
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Nephron sparing surgery in patients with metastatic renal cell carcinoma.
    Krishnamurthi V; Novick AC; Bukowski R
    J Urol; 1996 Jul; 156(1):36-9. PubMed ID: 8648832
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [A case of erythropoietin-producing renal cell carcinoma].
    Ishihara K; Shibuya T; Yokota E; Okamura T; Niho Y; Takei M
    Nihon Naika Gakkai Zasshi; 1988 Mar; 77(3):449-50. PubMed ID: 3404040
    [No Abstract]   [Full Text] [Related]  

  • 44. Ganglioside DSGb5, preferred ligand for Siglec-7, inhibits NK cell cytotoxicity against renal cell carcinoma cells.
    Kawasaki Y; Ito A; Withers DA; Taima T; Kakoi N; Saito S; Arai Y
    Glycobiology; 2010 Nov; 20(11):1373-9. PubMed ID: 20663960
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Nephron-sparing surgery for renal cell carcinoma.
    Novick AC
    Annu Rev Med; 2002; 53():393-407. PubMed ID: 11818482
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Norepinephrine producing renal cell carcinoma.
    Koh CJ; Bochner BH; Stein JP; Fedenko AN; Dequattro V; Skinner DG
    J Urol; 2001 Aug; 166(2):603. PubMed ID: 11458078
    [No Abstract]   [Full Text] [Related]  

  • 47. Kidney cancer: Novel targets in altered tumour metabolism in kidney cancer.
    Minton DR; Nanus DM
    Nat Rev Urol; 2015 Aug; 12(8):428-9. PubMed ID: 26215688
    [No Abstract]   [Full Text] [Related]  

  • 48. Nephron-sparing surgery.
    Lane BR; Novick AC
    BJU Int; 2007 May; 99(5 Pt B):1245-50. PubMed ID: 17441918
    [No Abstract]   [Full Text] [Related]  

  • 49. Simple renal cysts, atypical renal cysts, and renal cell carcinoma in von Hippel-Lindau disease: a lectin and immunohistochemical study in six patients.
    Kragel PJ; Walther MM; Pestaner JP; Filling-Katz MR
    Mod Pathol; 1991 Mar; 4(2):210-4. PubMed ID: 2047384
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Involvement of bone morphogenetic protein 2 in ossification of renal cell carcinoma.
    Yamasaki M; Nomura T; Mimata H; Nomura Y
    J Urol; 2004 Aug; 172(2):475-6. PubMed ID: 15247706
    [No Abstract]   [Full Text] [Related]  

  • 51. Nephron-sparing surgery in renal cell carcinoma: current perspectives on technical issues.
    González J; Cózar JM; Gómez A; Fernández-Pérez C; Esteban M
    Curr Urol Rep; 2015 Feb; 16(2):6. PubMed ID: 25633842
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Nephron sparing surgery for renal cell carcinoma in von Hippel-Lindau disease.
    Shinohara N; Nonomura K; Harabayashi T; Togashi M; Nagamori S; Koyanagi T
    J Urol; 1995 Dec; 154(6):2016-9. PubMed ID: 7500447
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Re: antitumoral effects of vasoactive intestinal peptide in human renal cell carcinoma xenografts in athymic nude mice.
    Atala A
    J Urol; 2014 Mar; 191(3):866-8. PubMed ID: 24522075
    [No Abstract]   [Full Text] [Related]  

  • 54. From genes to metabolomics in renal cell carcinoma translational research.
    Mulders PF
    Eur Urol; 2013 Feb; 63(2):252-3. PubMed ID: 23182551
    [No Abstract]   [Full Text] [Related]  

  • 55. Re: nephron sparing surgery for appropriately selected renal cell carcinoma between 4 and 7 cm results in outcome similar to radical nephrectomy.
    Ebert T; Weissbach L
    J Urol; 2004 Dec; 172(6 Pt 1):2483; author reply 2483. PubMed ID: 15538299
    [No Abstract]   [Full Text] [Related]  

  • 56. Re: Novel Kidney Segmentation System to Describe Tumour Location for Nephron-Sparing Surgery.
    Laguna MP
    J Urol; 2016 Jan; 195(1):61. PubMed ID: 26699953
    [No Abstract]   [Full Text] [Related]  

  • 57. Sarcomatoid chromophobe cell renal carcinoma: immunohistochemical and lectin study in one case.
    Gómez-Román JJ; Mayorga-Fernández M; Fernández-Fernández F; Val-Bernal JF
    Gen Diagn Pathol; 1997 Jul; 143(1):63-9. PubMed ID: 9269910
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Nephron sparing surgery of patients with renal cell carcinoma in a solitary kidney or bilateral renal cell carcinoma].
    Etoh H; Ueno K; Miyake H; Sugiyama T; Oka Y; Hara I; Nakamura I; Okada H; Arakawa S; Kamidono S
    Nihon Hinyokika Gakkai Zasshi; 1995 Jul; 86(7):1255-60. PubMed ID: 7637241
    [TBL] [Abstract][Full Text] [Related]  

  • 59. De novo renal cell carcinoma in an allograft kidney treated with nephron-sparing surgery: a case report.
    Numakura K; Satoh S; Tsuchiya N; Saito M; Nara T; Huang M; Tsuruta H; Akihama S; Inoue T; Narita S; Habuchi T
    Prog Transplant; 2014 Dec; 24(4):328-31. PubMed ID: 25488554
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Re: microRNA-155 is a predictive marker for survival in patients with clear cell renal cell carcinoma.
    Kapoor S
    Int J Urol; 2013 Jul; 20(7):739. PubMed ID: 23186135
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.